Tapan Mahendra Kadia

225PUBLICATIONS
383CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (225)

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 27, 2026
Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults.

Pageof 38

Frequent Collaborators

147 joint publications

Navel G Daver

146 joint publications

Courtney DiNardo

141 joint publications

Hagop M Kantarjian

132 joint publications

Elias Jabbour